Feb 11 | Nature News | Toxicologists at Johns Hopkins have charted the health risks of nearly 10,000 chemicals to help predict the toxicity of untested substances.
Feb 11 | Bio-IT World | 10X Genomics, whose GemCode platform allows for much better structural variant resolution and haplotype phasing during short-read sequencing experiments, has released a new system, Chromium, that builds on the efficiency of GemCode and can label RNA molecules from individual cells.
Feb 10 | Bio-IT World Brief | VeriStor is integrating SwiftStack’s object storage into its enterprise cloud services portfolio, the companies announced this week.
Feb 10 | Bio-IT World | This morning, AbbVie announced a partnership with Synlogic of Cambridge, Mass., to target inflammatory bowel disease with a strain of genetically engineered microbes that can sense and respond to symptoms as they occur.
Feb 10 | Forbes | The drug industry is pouring billions into R&D against Alzheimer's disease. Yet many people in the business will tell you not nearly enough is known about the underlying biology.
Feb 09 | The Verge | Sure Genomics, a startup based in Utah, launched a whole genome testing service today, but its plan to report a host of important health results is really testing the FDA.
Feb 08 | Slate | Larger and larger genetic studies are finding smaller and smaller effect sizes. What does this mean for drug development, clinical practice, and our view of mental illness?
Feb 08 | Bio-IT World | Scientists at MIT and Brigham and Women's Hospital have invented a "multiplexed editing regulatory assay" (MERA) to test large swathes of the genome in parallel for regulatory elements that can turn gene activity on and off over the course of a cell's development.
Feb 03 | Xconomy | A Cambridge startup is trying to remove extraneous variables from experiments with a "smart lab" that can better control for simple factors like temperature and humidity.
Feb 03 | Bio-IT World | The results of a months-long effort to sequence virus samples in the middle of the largest Ebola outbreak in history, using the handheld MinION DNA sequencer and a miniature mobile lab, have been published in Nature.
Feb 02 | Forbes | Is the future of biology in the cloud? Palo Alto-based venture fund, Andreesen Horowitz has created a new $200 million fund to invest in the idea.
Feb 01 | San Diego Union-Tribune | J. Craig Venter's company Human Longevity, Inc. has purchased LifebankUSA, a biobank that preserves stem cells from cord blood and placental tissue, growing an enterprise that will soon begin sequencing infants' genomes as a service.
Feb 01 | Nature News | A team at Francis Crick Institute has been permitted to use CRISPR-Cas9 technology in embryos for early-development research, but the work is still many steps away from genome-edited human beings.
Jan 29 | Bio-IT World | The latest products and announcements from around the industry, including a high-throughput protein conformation analyzer, and updates to the cloud-based genome analysis services of both DNAnexus and Seven Bridges.
Jan 28 | STAT | Harlan Krumholz, of the Yale Open Data Access project, speaks about a new proposal by the International Committee of Medical Journal Editors.
Jan 27 | New York Times | A massive genomic study provides researchers with a strong case for a biological mechanism involved in the disorder, and helps explain why it often begins at a relatively young age.
Jan 27 | Bio-IT World News Brief | Swiss drugs company Ferring Pharmaceuticals will fully fund the creation of a joint research center with the Karolinska Institutet of Sweden, to conduct human microbiome studies with an eye on new therapies.
Jan 26 | Bio-IT World News Brief | Illumina has purchased Conexio Genomics, an Australian company that was one of the first to develop products for using next-generation sequencing in matching tissue donors and recipients through HLA genotyping.
Jan 25 | Phenomena | A study using many parallel probes has revealed the spatial organization of different bacterial species in dental plaque. The strategy could be used to explore microbial ecology in all sorts of environments.
Jan 25 | Bio-IT World | Members of McGill University’s Centre of Genomics and Policy have published a global survey of restrictions on modifying the human genome, concluding that many regulations are vague and that bans or limitations often relax over time.